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Background: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract 
infection in infants. Preterm birth, in addition to several demographic and environmental 
factors, increases the risk for development of severe RSV infection. The purpose of this 
study was to describe differences in risk factors and protective factors between preterm birth 
(up to 35 weeks’ gestational age) and term infants hospitalized for RSV lower respiratory tract 
infection in the Russian Federation during the 2008–2009 RSV season.
Methods: Infants up to two years of age hospitalized for a lower respiratory tract infection in 
Moscow, St Petersburg, and Tomsk were tested for RSV . Patient data, including risk factors 
and protective factors for RSV , were captured at admission. Differences in these factors were 
compared between preterm and term patients.
Results: A total of 519 infants hospitalized for lower respiratory tract infection were included 
in the study. Of these, 197 infants (182 term and 15 preterm) tested positive for RSV . Of all 
hospitalizations, 51.7% (15/29) of preterm infants versus 37.1% (182/490) of term infants had 
confirmed RSV (P = 0.118). Among the RSV-positive patients, preterm infants were more likely 
to have a lower weight at admission (P = 0.050), be of multiple gestation (P , 0.001), have 
more siblings (P = 0.013), and have more siblings under the age of eight years (P , 0.007) 
compared with term patients. The preterm infants were less likely to be breastfed (P , 0.001) 
and more likely to have older mothers (P = 0.050).
Conclusion: Compared with term infants, RSV was a more prevalent cause of hospitalization 
for lower respiratory tract infection in preterm infants. Of infants hospitalized for RSV , preterm 
infants were more likely to have additional risk factors for severe RSV . These findings suggest 
that preterm infants may be exposed to a combination of more strongly interrelated risk factors 
for severe RSV than term infants.
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Introduction
Respiratory syncytial virus (RSV) is considered to be the most common cause of severe 
childhood respiratory infection requiring hospitalization.1,7 Almost all children will 
be exposed to RSV by two years of age,7 with the highest rate of infection occurring 
in months 2–6 of life.2 Up to 60% of children have been exposed to RSV before their 
first birthday. Most patients have mild symptoms of cough (98%), fever (75%), labored 
breathing (73%), and wheezing (65%).3 In infants infected with RSV , the symptoms 
are mild, and usually last 6–7 days. RSV is the leading viral cause of lower respiratory 
tract infection in infants younger than one year of age, and accounts for up to 80% 
of pneumonia and bronchiolitis-related hospital admissions during the RSV season.4 International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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However, 1%–2.5% of infants infected with RSV develop 
severe lower respiratory tract infection requiring hospital-
ization and possible supplemental oxygen and mechanical 
ventilation. In Croatia, a study collected data for eleven 
consecutive RSV seasons in children aged from birth to ten 
years, and found RSV to be the most common causative 
agent of acute respiratory infection in 42.2% and of lower 
respiratory tract infection in 49% of infants 0–6 months of 
age. RSV was found in 56.5% of infants with bronchiolitis 
and in 36.5% of infants with pneumonia.5 Mortality due 
to RSV is a concern. The mortality estimate due to severe 
cases requiring pediatric intensive care unit admission is 
8.6%.4 RSV does not elicit a substantial immune response, 
so reinfection is common.6
RSV represents a significant burden on the health care 
system. Among children under five years of age who pres-
ent with RSV-related illness, 25% are treated in emergency 
rooms and 3% require hospitalization.3 During the 1990s, 
hospitalization for RSV-associated illness cost an estimated 
$18 million annually in Canada alone.7 In 2000, the costs in 
the US associated with the approximately 86,000 hospitaliza-
tions of children under five years of age that were attributable 
to RSV infection totaled $394 million.8 Recent evidence 
suggests that the burden of disease is increasing in Western 
countries as admission rates increase due to RSV .9,10
To date, treatment has been limited to supportive mea-
sures, with no significant benefit from bronchodilators, 
adrenaline, steroids, or ribavirin.11 Prevention strategies are 
important, because it is clear that RSV-related illnesses pose 
a significant public health risk. Proper hygiene is required 
to prevent the spread of RSV. To date, the only available 
strategy with demonstrated effectiveness for RSV prevention 
in preterm and other high-risk infants is prophylaxis using 
anti-RSV antibodies.12
RSV is a ubiquitous pathogen responsible for epidem-
ics of disease globally, and the seasonality of RSV varies 
regionally. In general, RSV disease in temperate regions 
occurs in the cold season (ie, September through April), while 
outbreaks in tropical and subtropical areas north and south of 
the equator are seen in the cool, rainy seasons and in the cool, 
dry seasons, respectively.13,14 Along the equator, RSV occurs 
all year round, with increases in the rainy season.15
The prevalence of severe RSV-related illness varies 
around the world, likely due to differences in health care 
practices (ie, diagnostic testing, disease management, and 
access to care). The prevalence of environmental risk factors 
(ie, smoking, daycare use) may also account for such dif-
ferences. In the Russian Federation, infant mortality due to 
severe infection, including pneumonia, is 3–4 times greater 
than in other countries, such as Germany and the US.16–18 
Such estimates emphasize the importance of preventative 
innovations for infectious disease, particularly for children 
in countries more likely to experience severe and unfavorable 
outcomes.
In 2010, Tatochenko et al reported on the epidemiology 
of RSV in children up to two years of age hospitalized with 
lower respiratory tract infection in the Russian Federation.19 
The prevalence of RSV in this population and region had 
not been surveyed for over ten years,20 and Tatochenko et al 
were the first to characterize the associated risk factors for 
RSV in the Russian Federation.19 By secondary analysis 
of the data collected in the original study, this paper seeks 
to describe differences in both risk factors and protective 
factors for severe RSV infection between preterm and 
term infants hospitalized for RSV lower respiratory tract 
infection in the Russian Federation during the 2008–2009 
RSV season.
Methods
A prospective, multicenter, observational cohort study 
involving nine large university and pediatric hospitals was 
done in Moscow, St Petersburg, and Tomsk. Subjects were 
recruited between September 2008 and April 2009 during 
the cold season. All children aged up to two years who were 
hospitalized in participating centers for a lower respiratory 
tract infection were potentially eligible for inclusion. Lower 
respiratory tract infection was defined as a diagnosis of 
acute bronchiolitis, bronchitis, and/or pneumonia. Diagnosis 
was made based on: presence of clinical symptoms (cough, 
coryza, rhinorrhea, fever) and signs (wheezing, crackles or 
rales, retractions); imaging (chest radiograph indicative of 
lower respiratory tract infection) in the presence of at least 
one symptom; or by the presence of an apneic event with 
symptoms (fever or coryza), signs (wheezing, crackles or 
rales), or chest radiographic evidence of a lower respiratory 
tract infection. Exclusion criteria included any specific RSV 
prophylaxis within 100 days of admission.
Eligible children were enrolled in the study within 
24 hours of hospital admission and following informed 
parental consent, and RSV testing was performed via rapid 
immunochromatographic analysis of nasopharyngeal lavage 
(QuickStripe™ RSV, Savyon Diagnostics, Ashdod, Israel). 
The parent(s) of all enrolled children was interviewed, and 
their medical records were reviewed to obtain relevant patient 
and family medical and social history. Children who tested 
positive for RSV were followed for the duration of their International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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hospital stay, with additional data collected retrospectively 
based on a review of their hospital medical records. Children 
with RSV-negative lower respiratory tract infection were 
excluded from further data collection.
The study received approval from the institutional ethics 
boards of the participating centers. Written informed con-
sent was signed by at least one of the patient’s parents and 
obtained for each study participant prior to any study-related 
screening procedures.
statistical analysis
Descriptive statistics were used to describe the study cohort 
and to report the percentage of patients admitted with lower 
respiratory tract infection due to RSV . These results were 
then compared across the study groups (preterm versus term 
infants). For patients admitted to hospital with RSV , demo-
graphic data, risk factors, and protective factors were summa-
rized descriptively with the means and standard deviations for 
continuous variables and numbers and percentages calculated 
for categorical variables. Independent t-tests and Chi-square 
tests were applied to determine the statistical significance of 
continuous and categorical variables, respectively.   Statistical 
significance was set at P , 0.05. Statistical analysis was 
performed using SAS (SAS Institute Inc, Cary, NC).
Results
A total of 593 infants were assessed for eligibility and 520 
were enrolled in the study; one infant was removed after 
withdrawal of parental consent, resulting in 519 infants 
admitted to hospital with a lower respiratory tract infection, 
of which 197 (38%) had confirmed RSV infection. Of these 
519 patients, the mean age was 8.8 months, and 63.5% were 
male. A total of 490 infants were born at term and 29 were 
born preterm.
The mean age of the 197 RSV-positive patients was 7.5 
(± 5.9) months, and 60.9% were male. Table 1 compares the 
distribution of RSV status by gestational age of the patients 
hospitalized for a lower respiratory tract infection. Of preterm 
patients admitted to hospital for a lower respiratory tract 
infection, 15/29 (51.7%) had a confirmed RSV diagnosis, 
compared with 182/490 (37.1%) of term infants (P = 0.118). 
In addition to the difference in distribution between preterm 
and term infants, infants with a confirmed diagnosis of RSV 
were younger at the time of hospital admission (P , 0.001) 
and had a lower body weight (P , 0.001, Table 2).
Univariate analysis revealed statistically significant 
differences between RSV-positive term versus preterm sub-
groups in the proportion of patients with certain risk factors 
(Table 3). When compared with term infants, preterm patients 
had lower body weight at hospital admission (P = 0.050), 
were more likely to be of multiple gestation (P = 0.001), less 
likely to have ever been breastfed (P = 0.001), and had more 
siblings in the home (P = 0.013), including siblings under 
eight years of age (P = 0.007). The preterm infants were also 
more likely to have an older mother (P = 0.050).
The prevalence rates for passive and maternal smoking 
were high, but were not significantly different between the 
study groups. In addition, the educational level of parents 
and daycare attendance were not significantly different. In 
fact, the number of children attending daycare was low. 
Host factors, such as age at admission and gender, were not 
associated with an increased risk among the preterm patients. 
Likewise, medical factors, such as family history of atopy, 
wheezing/asthma, congenital heart disease, or chronic lung 
disease, were not disproportionately reported in the preterm 
group.
Discussion
While data regarding risk factors for severe RSV infection 
in infants, such as gestational age and breastfeeding, are well 
documented, there are no data for the impact of risk factors 
or protective factors in term versus preterm infants.
Premature infants are known to be at increased risk for 
severe RSV illness. Lung maturity occurs in the 37th week 
of gestation, so lung weights and volumes are significantly 
lower in preterm infants compared with term babies.21 
Premature lungs also have fewer and narrower alveoli 
compared with those in term babies.21 Given that much of 
the RSV-related morbidity can be understood as stemming 
from airway occlusion secondary to inflammation, epithelial 
sloughing, and edema, it is clear that those with the smallest 
and narrowest airways would be the most vulnerable.
Preterm infants also suffer from immature immune 
systems. Neutrophilic and complement functions are less 
Table 1 Distribution of rsV among infants hospitalized for a lower respiratory tract infection
Patients, RSV 
status
All patients 
(n = 519)
Term patients 
(n = 182)
Premature patients 
(GA , 36 weeks, n = 15)
P value
rsV + n (%) 197 (38.0) 182 (37.1) 15 (51.7) 0.118
Abbreviations: rsV, respiratory syncytial virus; GA, gestational age.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
136
Gooch et al
developed than in term babies. It has been hypothesized that 
complement activation serves to neutralize RSV , thus pre-
term infants are left with fewer defenses against the virus.21 
Preterm infants also lack the neutralizing antibodies from 
the mother that help them fight RSV infection.6
Among the subjects hospitalized with severe RSV disease 
in this study, preterm infants were more likely to have been 
exposed to several risk factors known to be associated with 
severe RSV illness. The cumulative effect of multiple risk 
factors potentially puts these infants at risk for more severe 
outcomes, but this needs to be explored further in sufficiently 
powered studies. Risk of hospitalization, a proxy for severe 
RSV disease, has been shown to increase incrementally with 
the number of risk factors present.22
Several risk factor models have been devised to identify 
the most important independent risk factors associated with 
severe RSV .23–25 The Pediatric Investigators Collaborative 
Network on Infections in Canada (PICNIC) study, published 
in 2004, examined risk factors associated with severe RSV 
disease (defined as hospitalization due to a lower respiratory 
tract infection with proven RSV infection) in preterm infants 
(gestational age under 35 weeks) over two consecutive sea-
sons.23 Independent risk factors identified were birth just before 
or during the RSV season, male gender, birth weight # 10th 
percentile in relation to gestational age, attending daycare, 
and preschool-aged siblings under six years of age, crowding 
(more than five people in the home), and exposure to cigarette 
smoke (more than two smokers in the home).23
Table 2 Patient demographics of rsV-positive and rsV-negative patients
Demographics All patients 
(n = 519)
RSV-positive infants 
(n = 197)
RSV-negative infants 
(n = 322)
P value*
Age, months (mean, sD) 8.8 (6.4) 7.5 (5.9) 9.7 (6.6) ,0.001
Weight at admission (kg) 
(mean, sD)
8.5 (2.7) 7.9 (2.6) 8.8 (2.0) ,0.001
Gender, male (n, %) 330 (63.5) 120 (60.9) 210 (65.2) 0.323
Premature (,36 weeks) (n, %) 29 (5.6) 15 (7.6) 14 (4.4) 0.118
congenital heart disease (n, %) 8 (1.5) 2 (1.0) 6 (1.9) 0.447
chronic lung disease (n, %) 1 (0.2) 1 (0.5) 0 (0) 0.201
Note: *P , 0.05 rsV-positive versus rsV-negative infants.
Abbreviations: rsV, respiratory syncytial virus; sD, standard deviation.
Table 3 Distribution of risk factors for infants hospitalized for a rsV-positive lower respiratory tract by subgroup
Term (n = 182) Premature (n = 15) P value
Host risk factors
Age (months) at admission (mean, sD) 7.4 (5.8) 8.0 (6.9) 0.768
GA (mean, sD) 39.4 (1.4) 32.4 (2.8) ,0.001
Weight (kg) at admission (mean, sD) 8.0 (2.5) 7.1 (2.9) 0.050
Gender (male, %) 112 (61.5) 8 (53.3) 0.531
Multiple gestation (n, %) 7 (3.9) 5 (33.3) ,0.001
ever breast-fed (n, %) 171 (94.0) 8 (53.3) ,0.001
Medical risk factors
congenital heart disease (n, %) 2 (1.10) 1 (0.0) 0.683
chronic lung disease (n, %) 1 (0.55) 0 (0.00) 0.773
neurological disease (n, %) 4 (2.2) 2 (13.3) 0.016
Family history of atopy (n, %) 35 (19.2) 3 (20.0) 0.942
Family history of wheezing/asthma (n, %) 22 (12.1) 1 (6.7) 0.530
Social risk factors
siblings (mean, sD) 0.7 (0.8) 1.3 (0.7) 0.013
siblings # 8 years (mean, sD) 0.6 (0.7) 1.1 (0.6) 0.007
Daycare attendance (n, %) 4 (2.2) 0 (0) 0.337
Individuals in home (mean, sD) 3.3 (1.2) 3.7 (0.9) 0.215
smokers in home (n, %) 84 (46.2) 6 (40.0) 0.646
Maternal smoking (n, %) 26 (14.4) 2 (13.3) 0.913
Mother’s age (mean years, sD) 29.0 (4.7) 32.9 (7.3) 0.050
Father’s age (mean years, sD)  32.4 (6.0) 35.1 (7.0) 0.167
Abbreviations: rsV, respiratory syncytial virus; sD, standard deviation.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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A second study of similar methodology and study popula-
tion was conducted in Spain.24 The results revealed similar 
risk factors to those found in PICNIC, and also identified 
breastfeeding for less than two months and family history 
of wheezing to be major risk factors for severe RSV . The 
results of this study were validated in a larger cohort study, 
FLIP-2, also conducted in Spain and published four years 
later.25 In contrast with the earlier FLIP study, breastfeeding 
for more than two months did not show a protective effect 
against RSV infection. The FLIP-2 study demonstrated a 
3.3–9.89 times greater risk of hospitalization among infants 
who had at least two risk factors, thus demonstrating the 
additive effects of risk factors.25
Overall, boys are at higher risk of hospitalization for RSV-
related illness than girls. Male gender has been shown to be an 
independent predictor for hospitalization due to RSV illness 
among preterm (gestational age 33–35 weeks) infants.23,25 
Preterm male infants were 91% more likely to be hospitalized 
for severe illness than their female counterparts.23
In this study, an increased total number of siblings and 
siblings under eight years of age in the home were found to 
be significantly more prevalent among the preterm infants 
compared with term infants. Preterm infants may be more 
vulnerable to the negative impact of household crowding, 
such as increased exposure to RSV through contact with 
more people. Preterm infants were also more likely to be the 
product of multiple gestation, a known risk factor for severe 
disease, and were less likely to have benefited from being 
breastfed.
There were limitations associated with this study. Firstly, 
and most importantly, the study was only able to assess the 
difference in frequency of risk factors between preterm and 
term infants already hospitalized for a severe RSV infection. 
It would be of interest to understand the risk factor prevalence 
in preterm and term infants in the general population, as well 
as those contracting RSV and not requiring hospitalization. 
A further limitation of this study was the small number of 
infants (15 preterm) examined, which limits the ability to 
draw definitive conclusions. It was impossible to perform 
subgroup analysis on categories of prematurity, ie, gestational 
age 32–35 weeks versus gestational age less than 32 weeks. 
A larger population of preterm infants would be required to 
confirm these findings.
Risk factors associated with serious complications of 
RSV have been identified. Understanding an infant’s risk 
can result in appropriate preventive interventions, whereby 
targeted prevention can both minimize disease cost and 
maximize the effectiveness of prophylaxis.
This study was conducted in only three regions in the 
Russian Federation, so these study findings may not be 
generalizable to other regions within Russia or other coun-
tries. At the time of the study, no specific RSV   prophylaxis 
(eg, palivizumab) was approved in the Russian Fed-
eration, therefore these data represent a prophylaxis-naive 
population.
Conclusion
In this study, risk factors associated with serious complica-
tions of RSV were identified, the key ones being a lower body 
weight, multiple gestation, more young siblings in the home, 
and limited breastfeeding. Results from this study indicate 
that, compared with infants born at term, RSV is a more preva-
lent cause for lower respiratory tract infection hospitalization 
in preterm infants. In addition, of infants hospitalized for RSV 
lower respiratory tract infection, preterm infants may be more 
susceptible to severe illness than term infants. The reasons 
for these differences require further evaluation.
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